211 related articles for article (PubMed ID: 14607350)
41. Role of common hypnotics on the phenotypic causes of obstructive sleep apnoea: paradoxical effects of zolpidem.
Carberry JC; Fisher LP; Grunstein RR; Gandevia SC; McKenzie DK; Butler JE; Eckert DJ
Eur Respir J; 2017 Dec; 50(6):. PubMed ID: 29284686
[TBL] [Abstract][Full Text] [Related]
42. Double blind comparison of zolpidem 20 mg versus flunitrazepam 2 mg in insomniac in-patients.
Frattola L; Maggioni M; Cesana B; Priore P
Drugs Exp Clin Res; 1990; 16(7):371-6. PubMed ID: 2092963
[TBL] [Abstract][Full Text] [Related]
43. Efficacy and safety of zolpidem extended release in elderly primary insomnia patients.
Walsh JK; Soubrane C; Roth T
Am J Geriatr Psychiatry; 2008 Jan; 16(1):44-57. PubMed ID: 18165461
[TBL] [Abstract][Full Text] [Related]
44. Effect of zolpidem on the efficacy of continuous positive airway pressure as treatment for obstructive sleep apnea.
Berry RB; Patel PB
Sleep; 2006 Aug; 29(8):1052-6. PubMed ID: 16944674
[TBL] [Abstract][Full Text] [Related]
45. Zolpidem in the treatment of short-term insomnia: a randomized, double-blind, placebo-controlled clinical trial.
Dockhorn RJ; Dockhorn DW
Clin Neuropharmacol; 1996 Aug; 19(4):333-40. PubMed ID: 8828996
[TBL] [Abstract][Full Text] [Related]
46. The effects of midazolam and temazepam on sleep and performance when administered in the middle of the night.
Roth T; Hauri P; Zorick F; Sateia M; Roehrs T; Kipp J
J Clin Psychopharmacol; 1985 Apr; 5(2):66-9. PubMed ID: 2859305
[TBL] [Abstract][Full Text] [Related]
47. Sensitivity of cyclic alternating pattern to prolonged pharmacotherapy: a 5-week study evaluating zolpidem in insomniac patients.
Terzano MG; Parrino L; Boselli M; Spaggiari MC; Di Giovanni G; Smerieri A
Clin Neuropharmacol; 1997 Oct; 20(5):447-54. PubMed ID: 9331522
[TBL] [Abstract][Full Text] [Related]
48. Pilot controlled double-blind study of the hypnotic effects of zolpidem in patients with chronic 'learned' insomnia: psychometric and polysomnographic evaluation.
Herrmann WM; Kubicki ST; Boden S; Eich FX; Attali P; Coquelin JP
J Int Med Res; 1993; 21(6):306-22. PubMed ID: 8143886
[TBL] [Abstract][Full Text] [Related]
49. On-the-road driving performance the morning after bedtime use of suvorexant 15 and 30 mg in healthy elderly.
Vermeeren A; Vets E; Vuurman EF; Van Oers AC; Jongen S; Laethem T; Heirman I; Bautmans A; Palcza J; Li X; Troyer MD; Wrishko R; McCrea J; Sun H
Psychopharmacology (Berl); 2016 Sep; 233(18):3341-51. PubMed ID: 27424295
[TBL] [Abstract][Full Text] [Related]
50. Long-term, non-nightly administration of zolpidem in the treatment of patients with primary insomnia.
Perlis ML; McCall WV; Krystal AD; Walsh JK
J Clin Psychiatry; 2004 Aug; 65(8):1128-37. PubMed ID: 15323600
[TBL] [Abstract][Full Text] [Related]
51. Residual effects of zolpidem, triazolam, rilmazafone and placebo in healthy elderly subjects: a randomized double-blind study.
Uemura SI; Kanbayashi T; Wakasa M; Satake M; Ito W; Shimizu K; Shioya T; Shimizu T; Nishino S
Sleep Med; 2015 Nov; 16(11):1395-1402. PubMed ID: 26498242
[TBL] [Abstract][Full Text] [Related]
52. A single-dose, randomized, double-blind, double dummy, placebo and positive-controlled, five-way cross-over study to assess the pharmacodynamic effects of lorediplon in a phase advance model of insomnia in healthy Caucasian adult male subjects.
Horoszok L; Baleeiro T; D'Aniello F; Gropper S; Santos B; Guglietta A; Roth T
Hum Psychopharmacol; 2014 May; 29(3):266-73. PubMed ID: 24911577
[TBL] [Abstract][Full Text] [Related]
53. Sleep in patients with chronic primary insomnia during long-term zolpidem administration and after its withdrawal.
Monti JM; Monti D; Estévez F; Giusti M
Int Clin Psychopharmacol; 1996 Dec; 11(4):255-63. PubMed ID: 9031992
[TBL] [Abstract][Full Text] [Related]
54. Effects of hypnotics on the sleep EEG of healthy young adults: new data and psychopharmacologic implications.
Feinberg I; Maloney T; Campbell IG
J Psychiatr Res; 2000; 34(6):423-38. PubMed ID: 11165310
[TBL] [Abstract][Full Text] [Related]
55. Hypnotics and actual driving performance.
O'Hanlon JF; Volkerts ER
Acta Psychiatr Scand Suppl; 1986; 332():95-104. PubMed ID: 3554901
[TBL] [Abstract][Full Text] [Related]
56. Residual effects of hypnotic drugs in aging drivers submitted to simulated accident scenarios: an exploratory study.
Meskali M; Berthelon C; Marie S; Denise P; Bocca ML
Psychopharmacology (Berl); 2009 Dec; 207(3):461-7. PubMed ID: 19798483
[TBL] [Abstract][Full Text] [Related]
57. Multicenter, double-blind, controlled comparison of zolpidem and triazolam in elderly patients with insomnia.
Roger M; Attali P; Coquelin JP
Clin Ther; 1993; 15(1):127-36. PubMed ID: 8458042
[TBL] [Abstract][Full Text] [Related]
58. Sedative, memory, and performance effects of hypnotics.
Roehrs T; Merlotti L; Zorick F; Roth T
Psychopharmacology (Berl); 1994 Oct; 116(2):130-4. PubMed ID: 7862941
[TBL] [Abstract][Full Text] [Related]
59. A double-blind comparison of the effects of temazepam and triazolam on residual, daytime performance in elderly insomniacs.
Nakra BR; Gfeller JD; Hassan R
Int Psychogeriatr; 1992; 4(1):45-53. PubMed ID: 1391671
[TBL] [Abstract][Full Text] [Related]
60. [Contribution of zolpidem in the management of sleep disorders].
Lavoisy J; Zivkovic B; Benavides J; Perrault GH; Robert P
Encephale; 1992; 18(4):379-92. PubMed ID: 1363657
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
